ロード中...
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago. Initial clinical trials were disappointing, resulting in a negative view of MMPs as therapeutic targets. As a better understanding of MMP biology and inhibitor pharmacokinetic properties emerged, it bec...
保存先:
| 出版年: | Cells |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769477/ https://ncbi.nlm.nih.gov/pubmed/31461880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8090984 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|